Levels of heparin-releasable TFPI are increased in first-ever lacunar stroke patients

Neurology

Volumn 78, Issue 7, 2012, Pages 493-498

  Knottnerus, I L H ^a,b,c   Winckers, K ^a,b   Ten Cate, H ^a,b   Hackeng, T M ^a,b   Lodder, J ^a,b   Rouhl, R P W ^a   Staals, J ^a,b   Govers Riemslag, J W P ^a,b   Bekers, O ^a   Van Oostenbrugge, R J ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 84858120571     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318246d6b7     Document Type: Article

References (31)

1. Bamford J, Sandercock P, Jones L, Warlow C. The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. Stroke 1987;18:545-551. (Pubitemid 17080565)
2. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003;34: 806-812.
3. Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease: systematic review and meta-analysis. Neurobiol Aging 2009;30:337-352.
4. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007;115:1285-1295. (Pubitemid 46594773)
5. Bajaj MS, Kuppuswamy MN, Saito H, et al. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci USA 1990;87:8869-8873. (Pubitemid 120007610)
6. Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2007;27:1687-1693. (Pubitemid 47207163)
7. Wun TC, Kretzmer KK, Girard TJ, et al. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 1988;263:6001-6004.
8. Lesnik P, Vonica A, Guerin M, et al. Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a). Arterioscler Thromb 1993;13: 1066-1075. (Pubitemid 23195809)
9. Broze GJ Jr, Lange GW, Duffin KL, MacPhail L. Heterogeneity of plasma tissue factor pathway inhibitor. Blood Coagul Fibrinolysis 1994;5:551-559. (Pubitemid 24301576)
10. Gori AM, Pepe G, Attanasio M, et al. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration. Thromb Haemost 1999;81: 589-593. (Pubitemid 29178947)
11. Lupu C, Poulsen E, Roquefeuil S, et al. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. Arterioscler Thromb Vasc Biol 1999;19:2251-2262. (Pubitemid 29422260)
12. Knottnerus IL, Govers-Riemslag JW, Hamulyak K, et al. Endothelial activation in lacunar stroke subtypes. Stroke 2010;41:1617-1622.
13. Rouhl RP, van Oostenbrugge RJ, Damoiseaux JG, et al. Haptoglobin phenotype may alter endothelial progenitor cell cluster formation in cerebral small vessel disease. Curr Neurovasc Res 2009;6:32-41.
14. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356. (Pubitemid 17104996)
15. Maurissen LF, Castoldi E, Simioni P, et al. Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals. J Thromb Haemost 2010;8: 750-758.
16. Ma KC, Olsson Y. Structural and vascular permeability abnormalities associated with lacunes of the human brain. Acta Neurol Scand 1993;88:100-107. (Pubitemid 23247971)
17. Lammie A. The role of oedema in lacune formation. Cerebrovasc Dis 1998;8:246.
18. Wardlaw JM, Dennis MS, Warlow CP, Sandercock PA. Imaging appearance of the symptomatic perforating artery in patients with lacunar infarction: occlusion or other vascular pathology? Ann Neurol 2001;50:208-215. (Pubitemid 32738146)
19. Wardlaw JM, Doubal F, Armitage P, et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 2009;65:194-202.
20. Arboix A, Marti-Vilalta JL. Lacunar stroke. Expert Rev Neurother 2009;9:179-196.
21. Knottnerus IL, Ten Cate H, Lodder J, et al. Endothelial dysfunction in lacunar stroke: a systematic review. Cerebrovasc Dis 2009;27:519-526.
22. He M, Wen Z, He X, et al. Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases. Thromb Res 2002;107:223-228. (Pubitemid 35435380)
23. Abumiya T, Yamaguchi T, Terasaki T, et al. Decreased plasma tissue factor pathway inhibitor activity in ischemic stroke patients. Thromb Haemost 1995;74:1050-1054.
24. Adams MJ, Thom J, Hankey GJ, et al. The tissue factor pathway in ischemic stroke. Blood Coagul Fibrinolysis 2006;17:527-532. (Pubitemid 44434962)
25. Ariens RA, Alberio G, Moia M, Mannucci PM. Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis. Thromb Haemost 1999; 81:203-207. (Pubitemid 29078303)
26. Hassan A, Hunt BJ, O'Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003;126:424-432. (Pubitemid 36172746)
27. Crawley JT, Lane DA. The haemostatic role of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 2008;28:233-242. (Pubitemid 351161194)
28. Morishita E, Asakura H, Saito M, et al. Elevated plasma levels of free-form of TFPI antigen in hypercholesterolemic patients. Atherosclerosis 2001;154:203-212. (Pubitemid 32008582)
29. Goto K, Ishii N, Fukasawa H. Diffuse white-matter disease in the geriatric population. A clinical, neuropathological, and CT study. Radiology 1981;141:687-695. (Pubitemid 12252202)
30. Mitchell CT, Kamineni A, Palmas W, Cushman M. Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2009;207:277-283.
31. Lindley RI, Wang JJ, Wong MC, et al. Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol 2009;8:628-634.